Pre-Open Stock Movers 10/15: (SNOA) (ME) (LVTX) Higher; (DCT) (SPCE) (CRSR) Lower (more...)

October 15, 2021 9:22 AM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Pre-Open Stock Movers

Duck Creek Technologies (NASDAQ: DCT) 21% LOWER; reported Q4 EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $70.9 million versus the consensus estimate of $69.09 million. Duck Creek Technologies sees Q1 2022 revenue of $68-70 million, versus the consensus of $68.7 million. Duck Creek Technologies sees FY2022 revenue of $292-300 million, versus the consensus of $303 million.

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) 21.7% HIGHER; announce that the Australian Therapeutic Goods Administration (TGA) has approved extended claims for Nanocyn® Disinfectant and Sanitizer, which is manufactured by Sonoma for its partner MicroSafe using Sonomas patented Microcyn® Technology.

Virgin Galactic (NYSE: SPCE) 16.3% LOWER; Announces Unity 23 Test Flight Rescheduled Following Completion of Vehicle Enhancement and Modification Period

23andMe Holding Co. (NASDAQ: ME) 7.5% HIGHER; gains on CNBC Mention. EMJ Capital founder Eric
Jackson called it the "next Roku."

Corsair Gaming, Inc. (NASDAQ: CRSR) 7.3% LOWER; expects Q3 net revenue to be approximately $391 million and full 2021-year net revenue to range from $1.825 billion to $1.925 billion. This falls below the consensus of $484.11 million and $2.08 billion, respectively.

LAVA Therapeutics N.V. (Nasdaq: LVTX) 7% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for the companys CD1d targeted GammabodyTM, LAVA-051, for the treatment of chronic lymphocytic leukemia (CLL). CLL is a form of leukemia characterized by progressive accumulation of abnormal lymphocytes in the peripheral blood, bone marrow and lymphoid tissues.

Alcoa (NYSE: AA) 5.8% HIGHER; reported Q3 EPS of $2.05, $0.39 better than the analyst estimate of $1.66. Revenue for the quarter came in at $3.1 billion versus the consensus estimate of $2.91 billion.

Matterport (NASDAQ: MTTR) 4.4% HIGHER; Wedbush added the stock to the firm’s Best Ideas List.

Flowserve Corp. (NYSE: FLS) 2.4% HIGHER; UBS upgraded from Neutral to Buy with a price target of $46.00 (from $42.00).

Goldman Sachs (NYSE: GS) 2.4% HIGHER; reported Q3 EPS of $14.93, $4.82 better than the analyst estimate of $10.11. Revenue for the quarter came in at $13.61 billion versus the consensus estimate of $11.67 billion.

Del Taco Restaurants (NASDAQ: TACO) 2.1% LOWER; reported Q3 EPS of $0.11, $0.01 better than the analyst estimate of $0.10. Revenue for the quarter came in at $124.3 million versus the consensus estimate of $124.86 million.

Broadcom Limited (NASDAQ: AVGO) 1.1% HIGHER; Goldman Sachs upgraded from Neutral to Buy.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

UBS, Goldman Sachs, Wedbush Best Ideas List, Pre-Open Losers, Pre-Open Winners, Pre Market Movers, FDA